J&J Study Shows Procrit Boosts Hemoglobin
home > MSN news
ORLANDO, Fla. -( Dow Jones)- Johnson & Johnson (JNJ) said a study showed that its Procrit drug increased red blood cell levels more than Amgen Inc.'s (AMGN) Aranesp in patients with cancer and anemia caused by chemotherapy. ... of the patients treated with Procrit reached the primary endpoint of increased ...
- link to J&J Study Shows Procrit Boosts Hemoglobin -
Last update: 05/26/2005